Read + Share
Amedeo Smart
Independent Medical Education
Gomez-Peralta F, Abreu C, Rizzo M. GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms. J Diabetes Complications 2023;37:108553.PMID: 37385011
Email
LinkedIn
Facebook
Twitter
Privacy Policy